Mohammad Esmaili, DPM
Podiatrist · Kensington, MDNPI 1780942318
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,600 of the $4,254 with a category attached, or 84.6%. Supreme Orthopedic Systems, LLC accounts for 86.5% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $2,534 and has fallen 99.4% since, to $15 in 2025.
Across 32 payments — averaging $132.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supreme Orthopedic Systems, LLC$4K
- Smith+Nephew$125
- Progenacare Global, LLC$98
- Treace Medical Concepts, Inc.$64
- Organogenesis Inc.$43
- Amgen$37
- plus $207 from 11 others
What the payments were for
- Food & beverage$65415%
- Education$3,60085%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supreme Orthopedic Systems, LLC | 5 | $3,681 |
| Smith+Nephew | 5 | $125 |
| Progenacare Global, LLC | 2 | $98 |
| Treace Medical Concepts, Inc. | 2 | $64 |
| Organogenesis Inc. | 2 | $43 |
| Amgen | 2 | $37 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $35 |
| Averitas Pharma Inc. | 1 | $28 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $22 |
| Kerecis Limited | 2 | $21 |
| Melinta Therapeutics, LLC | 1 | $20 |
| Convatec Inc. | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Stryker | 1 | $13 |
| Sebela Pharmaceuticals Inc. | 1 | $12 |
| Biopro, Inc. | 1 | $11 |
| Merck | 1 | $11 |
How this compares
$4,254 in reported general payments places this provider in the 85th percentile of 183 podiatrist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 31 | $822 |
| Ciclopirox | 22 | $624 |
| Mupirocin | 40 | $332 |
| Doxycycline Monohydrate | 16 | $224 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Kensington
- Ijeoma NwujuBethesda$601K
- David Linla Plata$75K
- Ira GottliebPasadena$25K
- Teresa HilliardHyattsville$19K
- Andreas KaikisHagerstown$17K
- Tiffany HohBaltimore$17K
- Shashank SrivastavaFrederick$15K
- Hayden HofflerCatonsville$15K
- Enzo LeonePasadena$15K
- Holly BeckSilver Spring$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.